Monday, 7 January 2019

Recent research suggests new therapeutic role for caffeine in neuropsychiatric disorders

(Mary Ann Liebert, Inc./Genetic Engineering News) An important new article reviews recently discovered properties of adenosine A2A receptor-dopamine D2 receptor (A2AR-D2R) and adenosine A1 receptor-dopamine D1 receptor (A1R-D1R) heteromers -- both of which are main targets for caffeine -- and discusses the therapeutic implications of these findings.

from EurekAlert! - Social and Behavioral Science http://bit.ly/2TCR8AN

No comments:

Post a Comment